Cloud Computing Magazine Click here to read latest issue Subscribe for FREE - Click Here IoT EVOLUTION …
We cover insider selling every week at 24/7 Wall St., and we like to remind our readers that just because an individual or 10% institutional owner is selling stock, that is no cause ... Pharmaceutical Inc. (NASDAQ: LGND), Robert Half Inc. …
The MLA Amendment also amended the upfront payments to the Company of Viking capital stock. If Viking completes …
Ligand Pharmaceuticals Incorporated LGND inked a deal to acquire Crystal Bioscience ... Consequently, Ligands shares have outperformed the industry year to date. The stock has surged 36.4% compared with the industry’s gain of 14.6% …
Mr. John L. Higgins is Chief Executive Officer, Director of the Company. He served as Chief Financial Officer at Connetics Corporation, a specialty pharmaceutical company, since 1997, and also served as Executive Vice President, Finance …
Most companies stock price histories show random or unpredictable movements ... Symbol Company # of Reports …
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on LGND at https://www.zacks.com/ap/LGND
Ligand Pharmaceuticals Incorporated LGND is scheduled to report second-quarter 2016 results ... Ligand is likely to beat earnings estimates this quarter. This is because a stock needs to have both a positive Earnings ESP and a Zacks …
It has outperformed by 1.89% the S&P500. The stock decreased 0.11% or $0.17 during the last trading session, …